Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG-1000 in uncomplicated acute influenza (phase 3, China)
CTR20232723Phase 3Completed
- Sponsor
- TaiGen Biotechnology Co., Ltd.
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of TG-1000 in Influenza A infection, influenza B, sponsored by TaiGen Biotechnology Co., Ltd.. Started Aug 2023; status: completed.
02
Drugs
TG-1000
03
Conditions
Influenza A infectioninfluenza B
Beyond the preview
Go deeper on CTR20232723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232723.